Sandalova, Sofya, Uğur Dal, and Arseniy Sandalov. 2026. “Early Post-Marketing Safety Signals of Anifrolumab in EudraVigilance: A Belimumab-Comparator Disproportionality Analysis”. International Journal of Medical Students, August. https://ijms.info/IJMS/article/view/4785.